NEUVIOR®
UK Pharma Infrastructure, AI & Medicines OS
NEUVIOR is a UK pharmaceutical group building infrastructure across medicines intelligence, resilient supply, applied research and pharmacy operations. PHARMORIS® is the flagship operating system at the centre of that strategy.
Proof Points & Recent Milestones
Early validation for the NEUVIOR® platform across innovation, governance, IP and lower-waste pharmaceutical manufacturing research.
Innovate UK Growth Catalyst – New Innovators Award
Awarded for PHARMORIS™ - Generics Optimisation Platform for NHS and Global Health.
Read MoreNHS DSPT Standards Met
Published for the 2025-26 cycle, strengthening NEUVIOR’s early NHS-facing governance posture.
Read MoreZYLON™ feasibility programme underway
Innovate UK-backed work on solvent recovery and bio-intelligent materials for lower-waste pharmaceutical production.
Read MorePHARMORIS®
The medicines value operating system for health systems.
What PHARMORIS does
Discover
Identify and rank the highest-value generic, off-patent, best-value medicines and supply-risk opportunities across fragmented datasets.
Justify
Convert shortlisted opportunities into decision-grade evidence packs with score drivers, provenance and confidence signals.
Deploy
Model owners, milestones, adoption curves and implementation pathways so value can be captured in real organisations.
Data & Assurance
Support each workflow with freshness indicators, explainable scoring, auditability and role-based access.
Benefits across the medicines ecosystem
For Patients
- Better continuity of access to appropriate medicines
- Fewer avoidable disruptions from shortages or switching
- More consistent care pathways across settings
- Lower-cost delivery without compromising quality or safety
For Healthcare Providers
- Prioritised action portfolios instead of dashboard overload
- Board-ready evidence for pharmacy, finance and executive teams
- Clear deployment plans with owners and milestones
- Stronger response to leakage, concessions and supply stress
For Health Systems
- Faster medicines value capture
- Reduced unwarranted variation and avoidable spend
- Improved supply resilience and governance visibility
- A clearer bridge from insight to operational execution
PHARMORIS® workflow
A medicines value workflow designed around Discover, Justify and Deploy rather than another passive dashboard.
Discover
Ingest medicines, pricing, shortage and product-identity data to surface the highest-value opportunities first.
Justify
Turn shortlisted opportunities into decision-grade evidence packs with rationale, confidence and source provenance.
Deploy
Model implementation across ICBs, trusts, providers and pharmacy teams with explicit owners, sequencing and value assumptions.
Review & Report
Track realised value, unresolved blockers, data freshness and portfolio progress through recurring review cycles.
ZYLON™
Applied manufacturing R&D exploring bio-intelligent materials and solvent recovery pathways for lower-waste pharmaceutical production.
Why ZYLON matters
Environmental Pathways
- Explores lower-waste and lower-emission manufacturing routes
- Examines solvent recovery opportunities in pharmaceutical production
- Builds around circular-design principles rather than one-off sustainability claims
- Creates a research base for future industrial partnerships
Process Assurance
- Feasibility work is framed for regulated manufacturing environments
- Quality, safety and reproducibility remain non-negotiable
- Uses data-led process analysis rather than speculative positioning
- Focuses on manufacturing reality as well as innovation potential
Strategic Value
- Extends NEUVIOR beyond software into broader pharmaceutical infrastructure
- Creates a sustainability and resilience narrative that investors can underwrite
- Supports future partnerships across manufacturing and materials science
- Shows long-term optionality beyond the initial PHARMORIS wedge
ZYLON™ development flow
A staged pathway from manufacturing problem selection to feasibility outputs and partnership-ready scale decisions.
Feasibility Mapping
Define target waste streams, bottlenecks and decarbonisation opportunities inside real pharmaceutical manufacturing contexts.
Process Intelligence
Apply AI-led analysis to solvent recovery, process efficiency and operational trade-offs.
Material Prototyping
Evaluate bio-intelligent materials and packaging concepts compatible with pharmaceutical quality expectations.
Industrial Pathway
Translate feasibility outputs into pilot opportunities, partner conversations and future scale-up decisions.
Assurance, governance & operating readiness
Start the conversation
NEUVIOR engages with health systems, investors, journalists, strategic partners and governance stakeholders who want infrastructure-grade thinking in medicines.
Book a PHARMORIS® demo
Request a product walkthrough for ICBs, NHS trusts, provider collaboratives, pharmacy leaders or strategic partners.
Investors & partnerships
Discuss the group model, protected product architecture, strategic capital and long-term infrastructure roadmap.
Media & policy briefings
Request founder commentary, background briefings or approved materials for coverage, diligence and stakeholder discussions.
Platform Updates
Subscribe to receive product releases, feature updates, and innovation insights